Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

114.20p
   
  • Change Today:
    -1.40p
  • 52 Week High: 121.60
  • 52 Week Low: 96.40
  • Currency: UK Pounds
  • Shares Issued: 539.52m
  • Volume: 194,547
  • Market Cap: 616.13m
  • RiskGrade: 119

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 1.5% 1.5%
Div Cover 3.8 3.8
Op Mrgn 13.2% 22.0%
ROCE 46.4%  
Latest F'cast
P/E 18.1 17.2
PEG 0.7 9.1
Pr/Revenue 3.8 3.2
Pr/Book 2.2  
Latest F'cast
Revenue 25.7% 17.1%
PBT 39.5% 131.8%
EPS 25.0% 1.9%
DPS 5.0% 1.4%

Alliance Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 191.06 42.08 6.51p 17.8 9.4 +2% 1.72p 1.5%
31-Dec-23 208.83 47.52 6.98p 16.6 2.3 +7% 1.81p 1.6%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Block Admission Application 17-Jun-2022 16:00 RNS
Total Voting Rights 08-Jun-2022 07:00 RNS
Notification of Major Holdings 26-May-2022 07:00 RNS

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 114.20p
Change Today -1.40p
% Change -1.21 %
52 Week High 121.60
52 Week Low 96.40
Volume 194,547
Shares Issued 539.52m
Market Cap 616.13m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.01% below the market average94.01% below the market average94.01% below the market average94.01% below the market average94.01% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Price Trend
86.22% above the market average86.22% above the market average86.22% above the market average86.22% above the market average86.22% above the market average
93.65% above the sector average93.65% above the sector average93.65% above the sector average93.65% above the sector average93.65% above the sector average
Income
70.77% below the market average70.77% below the market average70.77% below the market average70.77% below the market average70.77% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Growth
14.53% above the market average14.53% above the market average14.53% above the market average14.53% above the market average14.53% above the market average
15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 09-Jun-22 16-Dec-21
Paid 07-Jul-22 07-Jan-22
Amount 1.13p 0.56p

Trades for 29-Jun-2022

Time Volume / Share Price
10:09 5 @ 114.09p
10:07 2,792 @ 114.30p
10:06 2,450 @ 113.96p
10:06 2,792 @ 114.30p
10:06 5 @ 114.09p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page